Trial Profile
Evaluation of humoral immune response induced by a supplemental dose of inactivated poliovirus vaccine (IPV) administered intradermally or intramuscularly versus a dose of monovalent type 1 oral poliovirus vaccine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2022
Price :
$35
*
At a glance
- Drugs Poliovirus vaccine live oral (Primary) ; Poliovirus vaccine inactivated
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Sponsors Panacea Biotec
- 12 Feb 2009 Status changed from unconfirmed to completed as reported in the ISRCTN.
- 03 Dec 2008 New trial record.